- Inicio
- Productos
- Todos los Productos
- Excipientes
- Comprimidos
- Starch 1500®
Starch 1500® Almidón de maíz parcialmente pre-gelatinizado
El Starch 1500 es un excipiente farmacéutico confiable y único, el mismo esta fabricado exclusivamente paraser utilizado en la industria farmacéutica.
- Estabiliza activos sensibles a la humedad
- Provee una uniformidad de contenido excelente en baja dosis
- Cumple con los estándares regulatorios
El Starch 1500 es particularmente efectivo con activos sensibles a la humedad y en aplicaciones de baja dosis. Además, provee un rango único de funciones y un rendimiento flexible en una amplia variedad de aplicaciones, el Starch 1500 reduce los costos de proceso y materiales disminuyendo o eliminando los productos aglutinantes, super desintegrantes, altos niveles de lubricantes y deslizantes.
Comprimidos de alta calidad para recubrir
El Starch 1500 otorga una Buena dureza y baja friabilidad al comprimido ideal para el proceso de recubrimiento y empaque.
Alcance del producto
- El Starch 1500 se diseñó para cumplir con los requisitos regulatorios alrededor del mundo.
- El Starch 1500 LM: producto de bajo nivel de humedad (inferior al 7% de humedad). Cumple con las especificaciones de la PhEur y la USP/NF para el almidón pre gelatinizado.
- El Starch 1500 G: cumple con las especificaciones de la PhEur y USP/NF para almidón pre gelatinizado y los requisitos de la JPE para almidón parcialmente pregelatinizado
Contáctese con Colorcon para informarse sobre cómo el Starch 1500 puede mejorar su formulación y reducir sus costos.
Literatura del producto
Información de aplicación del producto Información General Folleto del producto Posters publicados Artículos / Papers publicadosInformación de aplicación del producto
Assessment of Low Dose Content Uniformity of Indomethacin
ドキュメントのダウンロードComparison of excipients and content uniformity in a formula containing a very low dose of indomethacin
Direct Compression Formulation of Loratadine (10 mg) Tablets
ドキュメントのダウンロードStarch 1500 in a lactose free, low dose active formulation, loratadine
Increasing the Compactability of Echinacea Purpurea Powder using Starch 1500®
ドキュメントのダウンロードTreating a high dose, poorly compressible herbal powder with Starch 1500 and fumed silica to increase compressibility
Lactose Replacement with Starch 1500® in a direct compression formula
ドキュメントのダウンロードRobust, more stable placebo tablet via DC compared to a similar lactose based formulation
Replacement of Di Basic Calcium Phosphate with Starch 1500® in a DC Formula
ドキュメントのダウンロードBenefits of using Starch 1500 in a DC placebo formulation replacing DCP
Starch 1500® as a Binder and Disintegrant in XCH (Xiaochaihu) Herbal Extract/Powder Tablet
ドキュメントのダウンロードHigh dose tablet formulation of XCH herbal extract/powder combination using Starch 1500/MCC in a high-shear granulation process
Starch 1500® used as a Binder Disintegrant in High Shear Wet Granulation Comparison to Povidone and Croscarmellose Sodium
ドキュメントのダウンロードStarch 1500 reduces overall cost and complexity of a formulation, in comparison to povidone and croscarmellose sodium
Wet Granulation of Acetaminophen with Starch 1500®
ドキュメントのダウンロードImprovement in tablet hardness and disintegration of Starch 1500 vs PVP
Información General
Free and Bound Water in Starch 1500® compared to other excipients
ドキュメントのダウンロードComparison of Water Activity vs LOD of commonly used excipients.
Technical Bulletin: Starch 1500®
ドキュメントのダウンロードTypical properties and key applications for Starch 1500 in oral solid dose formulation
Folleto del producto
Starch 1500® Product Brochure
ドキュメントのダウンロードIntroduction to Starch 1500 partially pregelatinized maize starch. Proven and Trusted Excipient for Performance and Versatility.
Posters publicados
AAPS 2005 - Particle Swelling and Coalescence to Gel Layer Formation
ドキュメントのダウンロードSwelling and coalescence behavior of HPMC and Starch 1500, in order to monitor the contribution to gel layer formation in matrices.
AAPS 2006 - Modulation of Drug Release from Hypromellose (HPMC) Matrices: Suppression of the Initial Burst Effect
ドキュメントのダウンロードMethod to minimize a burst of drug release typically observed in the early phases of release of highly soluble actives from METHOCEL matrices.
AAPS 2010 - Effect of Filler Type on Low Dose Acetaminophen Hydrophilic Matrix Formulations
ドキュメントのダウンロードEffect of four commonly used fillers in formulation and processing of HPMC matrices utilizing a high shear wet granulation process.
AAPS 2010 - Influence of Filler Type in the Blend Uniformity of Micronized Drugs
ドキュメントのダウンロードChoice of filler for a low-dose micronized drug to assist dispersibility and uniformity of the drug
AAPS 2011 - Barrier Membrane Coating of Hydrophilic Matrices of Sparingly Soluble Drug, Acetaminophen: A Strategy to Reduce Possible Food Effect
ドキュメントのダウンロードApplication of a barrier membrane (BM) coating consisting of Surelease and a pore-former, Opadry.
AAPS 2011 - Effect of Drug Particle Size on Blend Segregation and Content Uniformity of Low Dose Tablets
ドキュメントのダウンロードLow dose formulations of micronized hydrochlorothiazide (HCTZ) & the effect of drug particle size and load on dissolution rate
AAPS 2012 - Barrier Membrane Coated Hydrophilic Matrices: Robustness of Metoprolol Tartrate Release under Biorelevant Test Conditions – Impact of Media Composition
ドキュメントのダウンロードJoint poster - Ernst Moritz Arndt University & Colorcon
AAPS 2012 - Investigation of Synergistic Behavior of Excipients in Direct Compression Using a Rotary Press Simulator
ドキュメントのダウンロードUse of Starch 1500 in combination with MCC in direct compression.
AAPS 2012 - Stability of Ethylcellulose Barrier Membrane Coated Hydrochlorothiazide Matrices Comprising Starch 1500® or Lactose as Filler
ドキュメントのダウンロードStarch 1500 contributed to robustness of the barrier membrane coated matrix tablets.
AAPS 2015 - Eliminating Burst Release of Highly Soluble Drug from Hydrophilic Matrix Tablets Using Venlafaxine as a Model Drug
ドキュメントのダウンロードCombination of ionic low viscosity polymer with high viscosity Hypromellose reduced drug release within first 2 hours of dissolution.
AAPS 2015 - Enhancing the Stability of a Famotidine Tablet Formulation through Use of Starch 1500®
ドキュメントのダウンロードThe low water activity of Starch 1500 resulted in reduced degradation of famotidine. Starch/MCC formulation, coated with a PVA based Opadry® resulted in an improved accelerated stability in blister packages.
AAPS 2021 - Dissolution of Glucosamine Veterinary Chewable Tablets Using Ultra High Performance Liquid Chromatography-Charged Aerosol Detection es
ドキュメントのダウンロードCRS 2010 - Effect of Processing Conditions on Hypromellose Matrix Formulations of Acetaminophen Prepared by a High Shear Wet Granulation Process
ドキュメントのダウンロードProcessing guidelines for developing a hypromellose matrix formulation using a wet granulation process; with extra-granular addition of HPMC and Starch 1500 resulting in increased tablet hardness.
CRS 2011 - Use of Starch 1500® to Minimize Variability on Drug Release from Hypromellose Matrices
ドキュメントのダウンロードStarch 1500 in formulation design, supporting QbD study and minimizing formulation variability
Effect of Filler Type on the Stability of Polyethylene Oxide in a Hydrophilic Matrix Tablet
ドキュメントのダウンロードThe effect of various fillers on the oxidative stability of POLYOX in a matrix tablet
Artículos / Papers publicados
Formulating TCMs; East meets West
ドキュメントのダウンロードHow formulated coated tablets can make Traditional Chinese Medicine more palletable
Formulating Veterinary Chewable Tablets to Improve Palatability and Acceptance
ドキュメントのダウンロードFormulation of Acetylsalicylic Acid Tablets for Aqueous Enteric Film Coating
ドキュメントのダウンロードCombination of excipients for an aspirin tablet core suitable for aqueous enteric film coating
Formulation of Low Dose Medicines - Theory and Practice
ドキュメントのダウンロードEvaluating multiple excipients for content uniformity in a low dose application
Influence of Excipients on Drug Release from Hydroxypropyl Methylcellulose Matrices
ドキュメントのダウンロードJOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 93, NO. 11, Nov 2004
Starch Contrasts
ドキュメントのダウンロードReview of differences among pregelatinized starches - morphology, particle size and how the degree of modification effects functionality.
The Effect of Core Design and Formulation on the Quality of Film Coated Tablets
ドキュメントのダウンロードArticle published in Pharmaceutical Technology Europe - April 2005
